Cardiac fibrosis is a key factor to determine the prognosis in patient with myocardial infarction (MI). The aim of this study is to investigate whether the transcriptional factor paired-related homeobox 2 (Prrx2) regulates Wnt5a gene expression and the role in myocardial fibrosis following MI. The MI surgery was performed by ligation of left anterior descending coronary artery. Cardiac remodelling was assessed by measuring interstitial fibrosis performed with Masson staining. Cell differentiation was examined by analysis the expression of alpha-smooth muscle actin (α-SMA). Both Prrx2 and Wnt5a gene expressions were up-regulated in mice following MI, accompanied with increased mRNA and protein levels of α-SMA, collagen I and collagen III, compared to mice with sham surgery. Adenovirus-mediated gene knock down of Prrx2 increased survival rate, alleviated cardiac fibrosis, decreased infarction sizes and improved cardiac functions in mice with MI. Importantly, inhibition of Prrx2 suppressed ischaemia-induced Wnt5a gene expression and Wnt5a signalling. In cultured cardiac fibroblasts, TGF-β increased gene expressions of Prrx2 and Wnt5a, and induced cell differentiations, which were abolished by gene silence of either Prrx2 or Wnt5a. S U PP O RTI N G I N FO R M ATI O N Additional supporting information may be found online in the Supporting Information section. How to cite this article: Bai W-W, Tang Z-Y, Shan T-C, et al. Up-regulation of paired-related homeobox 2 promotes cardiac fibrosis in mice following myocardial infarction by targeting of Wnt5a.
| INTRODUC TI ON
Myocardial infarction (MI) is a leading cause of sudden death. 1 In response to MI, myocardial fibrosis is caused by aberrantly activated cardiac fibroblasts, excessive accumulation of collagen fibres in the extracellular matrix of the heart muscle, increased collagen concentration or imbalanced collagen composition. [2] [3] [4] The extracellular matrix is mainly composed of type I collagen and type III collagen, accounting for more than 90% of the total amount of myocardial interstitial collagen. 5 Maintenance of proper ratio of myocardial interstitial collagen is important for the integrity of cardiac function. 6 Molecular mechanisms that underlie cardiac fibrotic disorders are still mostly unclear, and no specific therapies exist for treatment of myocardial fibrosis.
The importance of Wnt signalling in developmental processes like cell proliferation, differentiation and migration has been recognized for decades. Wnt signal is relatively silent in adult heart tissue, 7 but re-activated after a variety of cardiac injuries ranging from acute ischaemic insult to chronic pressure overloading. 8 Abnormal Wnt pathway activation contributes to transforming growth factor-beta (TGF-β)-induced fibrotic remodelling in numerous adult fibrotic diseases including cardiac fibrosis after MI. 9 Wnt pathway has revealed new points of intervention that may lead to novel drug targets for small molecular weight compounds. 10, 11 However, how Wnt signalling is dysregulated in post-ischaemic heart needs further investigations.
Paired-related homeobox genes, including Prrx1 and Prrx2, are members of a subfamily of homeobox genes, which promote transcriptional activation by functional studies. 12 Mice that lack both Prrx1 and Prrx2 have profound defects in mesenchymal cell differentiation in the craniofacial region. 13 In vascular system, Prrx1 and Prrx2 are involved matrix modulation 14 and inhibits adipogenesis through regulated expression of TGF-β ligands, thereby activating TGF-β signalling. 15 Prrx2 has been reported to be induced by TGF-β and to increase the invasiveness of multiple cancer types through epithelial-mesenchymal transition. 16 However, the role of Prrx2 in ischaemia-induced cardiac remodelling is currently unknown.
As reported, both Prrx2 and Wnt5a were able to be up-regulated by TGF-β in myofibroblast and cancer cell. 16, 17 Therefore, we have been suggested that Wnt5a gene expression is directly up-regulated by Prrx2, which mediates cardiac fibrosis and delays the recovery of cardiac functions after MI. In this study, our findings indicate that is an effective approach to improve cardiac remodelling in patients with ischaemic heart diseases.
| MATERIAL S AND ME THODS
An expanded Methods section is included in the Supporting Information.
| Myocardial infarction (MI)
The surgery of MI was operated by ligation of left anterior descending coronary artery (LADCA) as described previously. 18, 19 
| Echocardiography
Echocardiography with standard parasternal and apical views was conducted in the left lateral recumbent position as we described previously. 20 Systolic or diastolic left ventricular internal diameter (LVDs or LVDd) were measured. Ejection fraction (EF) and fractional shortening (FS) were calculated.
| Statistical analysis
All quantitative results are expressed as mean ± SD. The normal distribution of data was tested by the Kolmogorov-Smirnov test before statistical comparisons, and the normality/equal variance was tested to determine whether ANOVA was appropriate. Multiple comparisons were analysed with a one-way ANOVA followed by Tukey post hoc tests or Bonferroni post hoc analyses. Comparisons between two groups were analysed by unpaired Student's t test between two groups. Chi-square test was applied to comparisons of survival rates. Further, overexpression of Prrx2 or Wnt5a mirrored the effects of TGF-β on cell differentiations of cardiac fibroblasts. Gene silence of Wnt5a also ablated cell differentiations induced by Prrx2 overexpression in cardiac fibroblasts. Mechanically, Prrx2 was able to bind with Wnt5a gene promoter to up-regulate Wnt5a gene expression.
In conclusions, targeting Prrx2-Wnt5a signalling should be considered to improve cardiac remodelling in patients with ischaemic heart diseases. (Table S2) .
Myocardial fibrosis, defined by the diffuse and disproportionate accumulation of collagen type I and III fibres in the interstitium, represents a final common lesion following a variety of myocardial injuries. 21 Thus, we detected the contents of collagen I and III, such as mRNA and protein in post-ischaemic hearts.
As expected, both collagen I and III were increased in hearts after ischaemia ( Figure 1A -C). Importantly, we also observed that the levels of α-SMA mRNA and protein were increased in ischaemic hearts after 30 post-operative days, compared to heart without ischaemia ( Figure 1A -C).
| Adenovirus-mediated gene knockdown of Prrx2 improves cardiac functions in mice following MI
We next investigated whether Prrx2 up-regulation is beneficial or detrimental in Apoe −/− mice following MI. As depicted in Figure 2A (Table S3 ).
We also examined heart functions at the 30th post-operative day by echocardiography ( Figure 2B ). The ligation of LADCA dramatically decreased EF ( Figure 2C ) and FS ( Figure 2D ), and increased LVDd ( Figure 2E ) and LVDs ( Figure 2F ) in mice with MI, compared with mice with sham surgery. Much more importantly, the impaired heart functions in mice with MI surgery were rescued by infecting mice with adenovirus expressing Prrx2 shRNA, compared to negative control shRNA.
| Prrx2 deficiency alleviates cardiac fibrosis in mice after MI
Cardiac fibrosis is a key factor to affect the recovery of heart functions in patients with ischaemia heart diseases. 22 As shown in Figure 2B ,G, the infarction sizes in mice injected with adenovirus expressing Prrx2 shRNA were smaller than mice injected with adenovirus expressing negative control shRNA at the 30th day after MI surgery. Prrx2 shRNA reduced the serious degree of interstitial fibrosis, as determined by Masson staining at the 30th post-operative days ( Figure 2B ,H), suggesting that Prrx2 upregulation is vital to mediate ischaemia-induced cardiac fibrosis in heart.
| Down-regulation of Prrx2 inactivates Wnt5a signalling in ischaemic heart in mice
Next, the effects of Prrx2 shRNA on Wnt signalling in Apoe −/− mice with MI were investigated by us. As illustrated in Figure 3A 
| TGF-β induces cell differentiation and activates Prrx2-Wnt5a signalling in cardiac fibroblasts
It has been reported that TGF-β induces cell differentiation of cardiac fibroblasts to play a crucial role in cardiac fibrogenesis. 23, 24 Then, we examined whether TGF-β activates Prrx2 and Wnt5a in cardiac fibroblasts by treating cells with TGF-β. As shown in Figure 4A 
| Cell differentiation induced by TGF-β is Prrx2 dependent in cardiac fibroblasts

| Wnt5a signalling is involved in cell differentiation in cardiac fibroblasts
The role of Wnt5a signalling in TGF-β-induced cell differentiation of cardiac fibroblasts was also investigated by infecting cells with adenovirus expressing Wnt5a shRNA or Wnt5a cDNA. As presented in As reported, Wnt5a has an autocrine or paracrine effect. 25 We determined if exogenous wnt5a produces the same induction of gene expression. As shown in Figure S3E 
| Prrx2 functions as a transcriptional factor to regulate Wnt5a gene expression
Considering that Prrx2 overexpression up-regulates both the mRNA level and protein expression of Wnt5a, we have been suggested that Figure 6A . To confirm the predicted site in Wnt5a promoter is required for increased Wnt5a gene expression in cardiac fibroblasts in response to TGF-β or Prrx2 overexpression, we constructed two promoter-reporter plasmids containing different binding site of Wnt5a promoter (ACAATTTC and AGTTAAAC). HEK293 cells were transfected with wild-type (WT) or mutated (MT) Wnt5a promoter-reporter plasmids along with vector or Prrx2 cDNA.
Promoter activity was analysed by luciferase assay in Figure 6B .
Prrx2 overexpression increased the transcriptional activity of WT-Wnt5a promoter. However, it had no any effects on the transcriptional activity of MT-Wnt5a promoter, implying that the regulatory element necessary for Prrx2-induced enhancement of Wnt5a gene expression is ACAATTTC.
The direct interaction between Prrx2 protein and Wnt5a promoter in cultured cardiac fibroblasts was determined by using immunoprecipitation (ChIP) analysis as described previously. 26 Compared to vehicle-treated cells, the Wnt5a gene promoter was positively amplified in samples from TGF-β-treated cells following ChIP with Prrx2 primary antibody but not with control IgG (Figure 6C ), suggesting that the positive amplification of the Wnt5a gene promoter is specific to Prrx2.
| TGF-β via Prrx2 up-regulates Wnt5a gene expression in cardiac fibroblasts
As seen in Figure 6D 
| TGF-β via Prrx2-Wnt5a signalling induces cell differentiation of cardiac fibroblasts in vitro
| D ISCUSS I ON
In the present study, we provided the first evidence that TGF-β upregulates Prrx2 to activate Wnt5a signalling through gene transcription, which induces cell differentiation of cardiac fibroblasts. As a result, this contributes to cardiac remodelling and the delayed recovery of heart functions after MI ( Figure S4 ). This novel mechanism not only uncovers a molecular mechanism by which Wnt5a signalling is re-activated in cardiac fibroblasts during ischaemia in vivo, but also provides a novel target for exploring new drugs to improve the prognosis of ischaemic heart disease.
F I G U R E 4 TGF-β induces cell differentiation and up-regulates
Prrx2 and Wnt5a in cardiac fibroblasts. Cultured cardiac fibroblasts were treated with TGF-β (10 ng/mL) for 24 h. A, Cell differentiation was determined by immunofluorescence analysis of α-SMA and quantitative analysis was shown. B, Gene expressions of Prrx2, Wnt5a, α-SMA, GAPDH, collagen I (Col I) and collagen III (Col III) in cells were measured by real-time PCR. C and D, Total cell lysates of cardiac fibroblasts were subjected to perform Western blotting analysis to detect protein levels of Prrx2, Wnt5a, α-SMA, Col I and Col III in C and quantitative analysis was performed in D. N is 5 in each group. *P < .05 vs Vehicle
The major discovery of this study is that Prrx2 regulates Wnt5a signalling via gene transcriptional manner in cardiac fibroblasts. To the best of our knowledge, this is the first study to identify Prrx2 as a transcriptional factor of Wnt5a, which was supported by the following evidence: (a) In Wnt5a gene promoter, the consensus sequence of Prrx2 is found, which is a putative Prrx2 binding site 'ACAATTTC'; transcriptional factor not only helps us to understand the molecular mechanism of cardiac remodelling, but also explores the novel role of Wnt5a in other aspects related to Prrx2.
Another discovery of this project is that MI-induced cardiac fibrosis is Prrx2 dependent. Cardiac fibrosis is an important pathological process contributing to the pathogenesis of cardiac remodelling after MI, which is a transition from an early inflammatory phase to fibrotic granulation and maturation stage of cardiac remodelling. 6 As a matter of fact, myocardial fibrosis is the end-points of cell differentiation, activation and proliferation of cardiac fibroblasts. 33, 34 Our study firstly explains the molecular mechanism by how TGF-β induces cell differentiation of cardiac fibroblasts in myocardial remodelling through Prrx2 up-regulation. As concerned to why Prrx2 F I G U R E 5 Cell differentiation induced by TGF-β is abolished by gene silence of Prrx2 in cardiac fibroblasts. Cultured cardiac fibroblasts were infected with adenovirus expressing negative control (NC) shRNA or Prrx2 shRNA for 48 h and then treated with TGF-β (10 ng/ mL) for 24 h. A, Cell differentiation was determined by immunofluorescence analysis of α-SMA and quantitative analysis was shown. B, Gene expressions of α-SMA, GAPDH, collagen I (Col I) and collagen III (Col III) in cells were measured by real-time PCR. C and D, Total cell lysates of cardiac fibroblasts were subjected to perform Western blotting analysis to detect protein levels of α-SMA, p-ERK, p-JNK, Col I, and Col III in C and quantitative analysis was performed in D. N is 5 in each group. *P < .05 vs NC plus Vehicle. # P < .05 vs NC plus TGF-β gene expression is elevated in cardiac fibroblasts after MI, an underlying mechanism is through the production of TGF-β, which is a key factor contributing to cardiac fibrosis in heart diseases 35 and TGF-β is able to induce both Prrx2 in cancer cells. 16 An unanswered question in this study that how TGF-β up-regulates Prrx2 gene expression in cardiac fibroblasts. The gene function may be regulated in transcriptional, post-transcriptional and post-translational levels. 36, 37 For example, microRNA (miR) comprises small, non-coding RNA that binds to a specific 3'-untranslated region of mRNA and inhibits mRNA translation or promotes mRNA degradation. 38, 39 It has been reported that Prrx2 mRNA is a target of miR-212-5p in breast cancer. 40 Interestingly, TGF-β up-regulates multiple microRNAs to produce its biological actions such as miR-124 and miR-101 as epigenetic factors. [41] [42] [43] Thus, we reasoned that TGF-β may increase Prrx2 expression via the specific miR.
Further investigations are needed.
F I G U R E 6
Prrx2 functions as a transcriptional factor of Wnt5a which is up-regulated by TGF-β. A, The prediction of binding site for Prrx2 in Wnt5a promoter. B, HEK293A cells were cotransfected with pGL3-promotor vector constructs expressing WT-Wnt5a-promoter containing ACAATTTC or MT-Wnt5a-promoter including AGTTAAAC plus Prrx2 cDNA plasmid. Cells were subjected to detect the relative luciferase activity. N is 5 per group. *P < .05 vs WT-Wnt5a-promoter. # P < .05 vs WT-Wnt5a-promoter plus Prrx2. C, Cultured cardiac fibroblasts were treated with TGF-β (10 ng/mL) for 24 h. Cells were subjected to detect the binding of Prrx2 to Wnt5a gene promoter by using ChIP method. For ChIP experiment, complex of chromatin/protein was pulled down by Prrx2 primary antibody. The promoter of Wnt5a was amplified by PCR. Positive control is the 10% of the total chromatin in the absence of immunoprecipitation. Negative control is the chromatin immunoprecipitated with IgG and amplified with Wnt5a promoter primers. The PCR production is 200 bp. D-F, Cultured cardiac fibroblasts were infected with adenovirus expressing negative control (NC) shRNA or Prrx2 shRNA for 48 h and then treated with TGF-β (10 ng/mL) for 24 h. Total cell lysates were subjected to detect gene expression of Wnt5a by real-time PCR in D and protein level of Wnt5a by Western blotting in E. Quantitative analysis of Wnt5a protein level was performed in F. N is 5 in each group. *P < .05 vs NC plus Vehicle. # P < .05 vs NC plus TGF-β. G-I, Cardiac fibroblasts were infected with adenovirus vector or expressing Prrx2 cDNA for 48 h. Cells were subjected to detect Wnt5a gene expression in G and protein level in H, and quantitative analysis of Wnt5a protein level was shown in I. N is 5 in each group. *P < .05 vs Vector Interestingly, we observed that knockdown of Prrx2 did not affect basal gene expression of Wnt5a in cardiac fibroblasts. We reasoned these possibilities to produce this difference. First, another Prrx2-induced transcription factor is promoting the increase instead of direct Prrx2 effect. Second, Prrx2 is partially involved in the cardiac fibrosis in resting condition.
An issue need to be discussed is why the death occurred at the first 10 days for MI mice. In the MI model alone, 32% of mice died of cardiac rupture and 12% mice died of heart failure. While in the MI model of mice with Prrx2 knockdown, 16% of mice died of cardiac rupture and 8% mice died of heart failure. Based on our investigations, we thought the major cause of death is cardiac rupture and Prrx2 knockdown can prevent cardiac rupture.
In summary, the present study proposes a role of Prrx2 in cardiac remodelling in response to ischaemic stress in heart. Specifically, when ischaemia is induced, Prrx2 is activated by TGF-β to enhance Wnt5a signalling, which in turn induces cell differentiation. The inhibition of either Prrx2 or Wnt5a serves to maintain resting condition of cardiac fibroblasts, which is ultimately not enough for promoting cardiac fibrosis. In perspective, Prrx2 or Wnt5a inhibitor maybe a new drug to treat ischaemia-related cardiovascular diseases, such as acute MI and stroke. F I G U R E 7 TGFβ1 via Prrx2-Wnt5a signalling induces cell differentiation in cardiac fibroblasts. A-D, Cultured cardiac fibroblasts were co-infected with adenovirus expressing Prrx2 shRNA plus vector or Wnt5a cDNA for 48 h and then treated with TGF-β (10 ng/mL) for 24 h. Cell differentiation was determined by immunofluorescence analysis of α-SMA and quantitative analysis was shown in A. Gene expressions of Wnt5a, α-SMA, GAPDH, collagen I (Col I) and collagen III (Col III) in cells were measured by real-time PCR in B. Total cell lysates of cardiac fibroblasts were subjected to perform Western blotting analysis to detect protein levels of Wnt5a, α-SMA, Col I, and Col III in C and quantitative analysis was performed in D. N is 5 in each group. *P < .05 vs Vector. E-H, Cardiac fibroblasts were co-infected with adenovirus expressing Prrx2 cDNA plus negative control (NC) shRNA or Wnt5a shRNA for 48 h. Cells were subjected to detect immunofluorescence analysis of α-SMA and quantitative analysis was shown in E, gene expressions of Wnt5a, α-SMA, GAPDH, Col I and Col III in F, protein levels of Wnt5a, α-SMA, Col I, and Col III in G and H. N is 5 in each group. *P < .05 vs NC plus Prrx2
